Beth Faiman, PhD, CNP, a Nurse Practitioner and Clinical Researcher at Cleveland Clinic specializing in multiple myeloma, joins the Cancer Advances podcast to discuss updates in managing relapsed and refractory multiple myeloma. Listen as Dr. Faiman talks about advancements in treatment, including proteasome inhibitors, monoclonal antibodies, and bispecific antibodies, which improve both survival rates and the quality of life for patients. She also highlights key research presented at the International Myeloma Society meeting, focusing on CAR T-cell therapy, transplant eligibility criteria, and personalized treatment planning.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Erich G. Anderer, Chief of the Division of Neurosurgery and Surgical Director of Perioperative Services at NYU Langone Hospital–Brooklyn
09 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Nolan Wessell, Assistant Professor and Well-being Co-Director, Department of Orthopedic Surgery, Division of Spine Surgery, University of Colorado School of Medicine
08 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 1AM EST
08 Dec 2025
NPR News Now